Trial intelligence / Profile preview

FLUAD-H5N1 in adults and elderly

NCT00434733Phase 3Completed

Sponsor
Novartis
Start
Jan 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) in Avian influenza H5N1 (H5N1), sponsored by Novartis. Started Jan 2007; status: completed.

02

Drugs

Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
03

Conditions

Avian influenza H5N1 (H5N1)

Beyond the preview

Go deeper on NCT00434733.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00434733.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call